FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W4221010202> ?p ?o ?g. }

• W4221010202 abstract "Abstract Background Host factors such as angiotensin-converting enzyme 2 (ACE2) and the transmembrane protease, serine-subtype-2 (TMPRSS2) are important factors for SARS-CoV-2 infection. Clinical and pre-clinical studies demonstrated that RAAS-blocking agents can be safely used during a SARS-CoV-2 infection but it is unknown if DPP-4 inhibitors or SGLT2-blockers may promote COVID-19 by increasing the host viral entry enzymes ACE2 and TMPRSS2. Methods We investigated telmisartan, linagliptin and empagliflozin induced effects on renal and cardiac expression of ACE2, TMPRSS2 and key enzymes involved in RAAS (REN, AGTR2, AGT) under high-salt conditions in a non-diabetic experimental 5/6 nephrectomy (5/6 Nx) model. In the present study, the gene expression of Ace2 , Tmprss2 , Ren , Agtr2 and Agt was assessed with qRT-PCR and the protein expression of ACE2 and TMPRSS2 with immunohistochemistry in the following experimental groups: Sham + normal diet (ND) + placebo (PBO); 5/6Nx + ND + PBO; 5/6Nx + high salt-diet (HSD) + PBO; 5/6Nx + HSD + telmisartan; 5/6Nx + HSD + linagliptin; 5/6Nx + HSD + empagliflozin. Results In the kidney, the expression of Ace2 was not altered on mRNA level under disease and treatment conditions. The renal TMPRSS2 levels (mRNA and protein) were not affected, whereas the cardiac level was significantly increased in 5/6Nx rats. Intriguingly, the elevated TMPRSS2 protein expression in the heart was significantly normalized after treatment with telmisartan, linagliptin and empagliflozin. Conclusions Our study indicated that there is no upregulation regarding host factors potentially promoting SARS-CoV-2 virus entry into host cells when the SGLT2-blocker empagliflozin, telmisartan and the DPP4-inhibitor blocker linagliptin are used. The results obtained in a preclinical, experimental non-diabetic kidney failure model need confirmation in ongoing interventional clinical trials." @default.
• W4221010202 created "2022-04-03" @default.
• W4221010202 creator A5012901813 @default.
• W4221010202 creator A5015465551 @default.
• W4221010202 creator A5019414372 @default.
• W4221010202 creator A5022687335 @default.
• W4221010202 creator A5023246606 @default.
• W4221010202 creator A5028462736 @default.
• W4221010202 creator A5041893528 @default.
• W4221010202 creator A5068292920 @default.
• W4221010202 creator A5083532124 @default.
• W4221010202 creator A5085321316 @default.
• W4221010202 date "2022-03-24" @default.
• W4221010202 modified "2023-10-09" @default.
• W4221010202 title "Regulation of SARS CoV-2 host factors in the kidney and heart in rats with 5/6 nephrectomy—effects of salt, ARB, DPP4 inhibitor and SGLT2 blocker" @default.
• W4221010202 cites W1644254267 @default.
• W4221010202 cites W1831301545 @default.
• W4221010202 cites W1973460974 @default.
• W4221010202 cites W1978525739 @default.
• W4221010202 cites W1990985479 @default.
• W4221010202 cites W1997771891 @default.
• W4221010202 cites W1998964868 @default.
• W4221010202 cites W2060204625 @default.
• W4221010202 cites W2083695720 @default.
• W4221010202 cites W2100558876 @default.
• W4221010202 cites W2101629192 @default.
• W4221010202 cites W2104103470 @default.
• W4221010202 cites W2104620139 @default.
• W4221010202 cites W2104899725 @default.
• W4221010202 cites W2119111857 @default.
• W4221010202 cites W2129366803 @default.
• W4221010202 cites W2144370633 @default.
• W4221010202 cites W2167384912 @default.
• W4221010202 cites W2167467272 @default.
• W4221010202 cites W2171671715 @default.
• W4221010202 cites W2296112327 @default.
• W4221010202 cites W2310714687 @default.
• W4221010202 cites W2916835086 @default.
• W4221010202 cites W2989779046 @default.
• W4221010202 cites W3007031960 @default.
• W4221010202 cites W3009912996 @default.
• W4221010202 cites W3012088820 @default.
• W4221010202 cites W3014027512 @default.
• W4221010202 cites W3016250474 @default.
• W4221010202 cites W3021815243 @default.
• W4221010202 cites W3035135361 @default.
• W4221010202 cites W3042832221 @default.
• W4221010202 cites W3047903500 @default.
• W4221010202 cites W3081332142 @default.
• W4221010202 cites W3084085407 @default.
• W4221010202 cites W3088249173 @default.
• W4221010202 cites W3091862525 @default.
• W4221010202 cites W3091863087 @default.
• W4221010202 cites W3091902939 @default.
• W4221010202 cites W3094104267 @default.
• W4221010202 cites W3099864060 @default.
• W4221010202 cites W3106776335 @default.
• W4221010202 cites W3113041328 @default.
• W4221010202 cites W3114705283 @default.
• W4221010202 cites W3150791165 @default.
• W4221010202 cites W3166974598 @default.
• W4221010202 cites W4200361613 @default.
• W4221010202 doi "https://doi.org/10.1186/s12882-022-02747-1" @default.
• W4221010202 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/35331159" @default.
• W4221010202 hasPublicationYear "2022" @default.
• W4221010202 type Work @default.
• W4221010202 citedByCount "2" @default.
• W4221010202 countsByYear W42210102022022 @default.
• W4221010202 crossrefType "journal-article" @default.
• W4221010202 hasAuthorship W4221010202A5012901813 @default.
• W4221010202 hasAuthorship W4221010202A5015465551 @default.
• W4221010202 hasAuthorship W4221010202A5019414372 @default.
• W4221010202 hasAuthorship W4221010202A5022687335 @default.
• W4221010202 hasAuthorship W4221010202A5023246606 @default.
• W4221010202 hasAuthorship W4221010202A5028462736 @default.
• W4221010202 hasAuthorship W4221010202A5041893528 @default.
• W4221010202 hasAuthorship W4221010202A5068292920 @default.
• W4221010202 hasAuthorship W4221010202A5083532124 @default.
• W4221010202 hasAuthorship W4221010202A5085321316 @default.
• W4221010202 hasBestOaLocation W42210102021 @default.
• W4221010202 hasConcept C126322002 @default.
• W4221010202 hasConcept C134018914 @default.
• W4221010202 hasConcept C2775887513 @default.
• W4221010202 hasConcept C2775946041 @default.
• W4221010202 hasConcept C2778042024 @default.
• W4221010202 hasConcept C2779134260 @default.
• W4221010202 hasConcept C2779716603 @default.
• W4221010202 hasConcept C2780031085 @default.
• W4221010202 hasConcept C2780091579 @default.
• W4221010202 hasConcept C2910068830 @default.
• W4221010202 hasConcept C3008058167 @default.
• W4221010202 hasConcept C524204448 @default.
• W4221010202 hasConcept C555293320 @default.
• W4221010202 hasConcept C71924100 @default.
• W4221010202 hasConcept C84393581 @default.
• W4221010202 hasConcept C98274493 @default.
• W4221010202 hasConceptScore W4221010202C126322002 @default.
• W4221010202 hasConceptScore W4221010202C134018914 @default.
• W4221010202 hasConceptScore W4221010202C2775887513 @default.
• W4221010202 hasConceptScore W4221010202C2775946041 @default.

• next